Announcements
- 2024.03.04 Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
- 2024.02.28 VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS SUCCESSFULLY COMPLETED THE FIRST CLINICAL IMPLANTATION IN BRAZIL
- 2024.02.06 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
- 2024.01.26 VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY THE CHAIRMAN, EXECUTIVE DIRECTOR AND SENIOR MANAGEMENT
- 2024.01.25 VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE H SHARE SCHEME
- 2024.01.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
- 2024.01.03 VOLUNTARY ANNOUNCEMENT THE PFO OCCLUDER SYSTEM OMNISEAL SUCCESSFULLY COMPLETED THE FIRST CLINICAL IMPLANTATION
- 2024.01.02 VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS
- 2023.12.29 VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE H SHARE SCHEME
- 2023.12.21 DISCLOSEABLE TRANSACTION ENTERED INTO THE EQUITY TRANSFER AGREEMENT
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
